Nicotinsyrerelaterede bivirkninger Følgende nicotinsyrerelaterede bivirkninger er set i kliniske undersøgelser eller efter markedsføring med andre nicotinsyrepræparater i ukendt frekvens eller i kliniske undersøgelser med Tredaptive (eller nicotinsyrekomponenten af Tredaptive) hos < 1% af de behandlede patienter:
Nicotinic acid-related adverse reactions The following nicotinic acid-related adverse reactions have been seen in clinical trials or post-marketing experience with other nicotinic acid medicinal products at unknown frequency or in clinical trials with Tredaptive (or the nicotinic acid component of Tredaptive) in < 1% of the patients treated: